ImmuPharma PLC (IMM)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
1.475p
Buy
1.595p
-0.025p (-1.66%)
Prices updated at 05 Sep 2024, 16:29 BST
| Prices minimum 15 mins delay
Prices in GBX
ImmuPharma PLC is a drug discovery and development company. The company along with its subsidiaries is engaged in the research and development of novel drugs based on peptide therapeutics to treat serious medical conditions including autoimmune diseases.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
In the news
Sharecast service unavailable
Press releases
06 Aug 202428 Jun 202406 Jun 202405 Jun 202405 Jun 202403 Jun 202403 May 202424 Apr 202419 Apr 202402 Apr 2024
Key dates
| Forecast date | |
|---|---|
| Annual general meeting | Jun 2025 |
| Final results | Jun 2025 |
| Annual report | Jun 2025 |
| Half yearly results | - |
| Previous date | |
|---|---|
| Annual general meeting | Jun 2024 |
| Final results | Jun 2024 |
| Annual report | Jun 2024 |
Company reports
31 Dec 2022
Annual Report 